<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - recent issues</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of recent issues (covers the latest 3 issues, including the current issue) </description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/365?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/367?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/371?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/383?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/391?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/399?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/409?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/415?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/421?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/429?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/435?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/443?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/451?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/457?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/463?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/475?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/481?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/491?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/5/4/493?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1">
<title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep046</dc:identifier>
<dc:title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>131</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>129</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1">
<title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1</link>
<description><![CDATA[
<p>Static magnetic field (SMF) therapy, applied via a permanent magnet attached to the skin, is used by people worldwide for self-care. Despite a lack of established SMF dosage and treatment regimens, multiple studies are conducted to evaluate SMF therapy effectiveness. Our objectives in conducting this review are to:(i) summarize SMF research conducted in humans; (ii) critically evaluate reporting quality of SMF dosages and treatment parameters and (iii) propose a set of criteria for reporting SMF treatment parameters in future clinical trials. We searched 27 electronic databases and reference lists. Only English language human studies were included. Excluded were studies of electromagnetic fields, transcranial magnetic stimulation, magnets placed on acupuncture points, animal studies, abstracts, posters and editorials. Data were extracted on clinical indication, study design and 10 essential SMF parameters. Three reviewers assessed quality of reporting and calculated a quality assessment score for each of the 10 treatment parameters. Fifty-six studies were reviewed, 42 conducted in patient populations and 14 in healthy volunteers. The SMF treatment parameters most often and most completely described were site of application, magnet support device and frequency and duration of application. Least often and least completely described were characteristics of the SMF: magnet dimensions, measured field strength and estimated distance of the magnet from the target tissue. Thirty-four (61%) of studies failed to provide enough detail about SMF dosage to permit protocol replication by other investigators. Our findings highlight the need to optimize SMF dosing parameters for individual clinical conditions before proceeding to a full-scale clinical trial.</p>
]]></description>
<dc:creator><![CDATA[Colbert, A. P., Wahbeh, H., Harling, N., Connelly, E., Schiffke, H. C., Forsten, C., Gregory, W. L., Markov, M. S., Souder, J. J., Elmer, P., King, V.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem131</dc:identifier>
<dc:title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>139</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>133</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1">
<title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1</link>
<description><![CDATA[
<p>The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of &beta;-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of &beta;-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of &beta;-thalassemia patients, (iii) good correlation of <I>in vivo</I> and <I>in vitro</I> results of HbF synthesis and -globin mRNA accumulation indicates that <I>in vitro</I> testing might be predictive of <I>in vivo</I> responses and (iv) combined use of different inducers might be useful to maximize HbF, both <I>in vitro</I> and <I>in vivo</I>. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from <I>Angelica arcangelica</I> and <I>Aegle marmelos</I>, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from <I>Streptomyces hygroscopicus</I>.</p>
]]></description>
<dc:creator><![CDATA[Bianchi, N., Zuccato, C., Lampronti, I., Borgatti, M., Gambari, R.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem139</dc:identifier>
<dc:title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>151</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>141</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1</link>
<description><![CDATA[
<p>Since 1997, the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine of Graz Medical University has been dealing with the demystification of acupuncture and examining, using non-invasive methods, how different stimulation modalities (manual needle acupuncture, laserneedle acupuncture and electro acupuncture) affect peripheral and central functions. Laser is also an important instrument for acupuncture. One only needs to mention the treatment of children or of patients with needle phobia. The laserneedle acupuncture, which was examined scientifically for the first time in Graz, represents a new painless acupuncture method for which up to ten laserneedles are glued to the skin, but not stuck into it. This first part of the short review article summarizes some of the peripherally measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years.</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem145</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>158</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>153</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1">
<title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1</link>
<description><![CDATA[
<p>This is the final article in a four part series reviewing the influence of humor and laughter on physiological and psychological well-being. This final article reviews the evidence for the effect of sense of humor, exposure to a humor stimulus and laughter on various immune system components, with a focus on the effects of laughter on natural killer cell cytotoxicity.</p>
]]></description>
<dc:creator><![CDATA[Bennett, M. P., Lengacher, C.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem149</dc:identifier>
<dc:title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>164</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>159</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1">
<title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1</link>
<description><![CDATA[
<p>While the ancient Egyptians and Greeks used honey for wound care, and a broad spectrum of wounds are treated all over the world with natural unprocessed honeys from different sources, Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> has been one of the first medically certified honeys licensed as a medical product for professional wound care in Europe and Australia. Our experience with medical honey in wound care refers only to this product. In this review, we put our clinical experience into a broader perspective to comment on the use of medical honey in wound care. More prospective randomized studies on a wider range of types of wounds are needed to confirm the safety and efficacy of medical honey in wound care. Nonetheless, the current evidence confirming the antibacterial properties and additional beneficial effects of medical honey on wound healing should encourage other wound care professionals to use CE-certified honey dressings with standardized antibacterial activity, such as Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> products, as an alternative treatment approach in wounds of different natures.</p>
]]></description>
<dc:creator><![CDATA[Simon, A., Traynor, K., Santos, K., Blaser, G., Bode, U., Molan, P.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem175</dc:identifier>
<dc:title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>173</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>165</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1">
<title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1</link>
<description><![CDATA[
<p><I>Ki</I> (in Japanese) or <I>Qi</I> (in Chinese) is the key concept in Eastern medicine, Eastern philosophy, as well as in martial arts. We explain the philosophical and psychological background of <I>Ki</I>. We emphasize that the unique aspects of Eastern philosophy are &lsquo;non-linearity&rsquo; and &lsquo;holistic&rsquo; approach. We then present physics aspect of <I>Ki</I>. Our experiments demonstrated that a &lsquo;<I>Ki</I>-beam&rsquo; carries &lsquo;entropy&rsquo; (or information), which is different from &lsquo;energy&rsquo;. We introduce our experience of having taught <I>Ki</I> to 37 beginners in the United States through the Nishino Breathing Method. If beginners had martial arts training or a strong background in music or dance, about half of them could sense <I>Ki</I> within 10 weeks (1 h class per week) of practice.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen005</dc:identifier>
<dc:title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>183</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>175</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1">
<title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1</link>
<description><![CDATA[
<p>Acupuncture is an ancient Chinese therapy with its mode of action unclear and efficacy inconclusive. A lack of attention given to the role of psychosocial context presented in clinical provision of acupuncture may mainly account for the current dilemma in acupuncture research. This psychosocial context induces various cognitive and affective processes in the patient while receiving this treatment. On the basis of the analysis of these psychological factors involved in clinical provision of acupuncture and in light of prior studies on the placebo effect, the author hypothesizes that acupuncture works through potentiation and modulation of a highly organized and somatotopic network of endogenous opioids that links expectation, attention and body schema. This hypothesis, which focuses on the contextual factors involved in clinical provision of acupuncture, has immediate clinical and experimental implications and will take the acupuncture debate much further forward.</p>
]]></description>
<dc:creator><![CDATA[Liu, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen002</dc:identifier>
<dc:title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>193</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>185</prism:startingPage>
<prism:section>Hypothesis</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1">
<title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1</link>
<description><![CDATA[
<p>Licorice is commonly used as a cure for digestive disorders and as a detoxification agent in East Asia. This study investigated the protective effect of licorice water extract against cadmium (CdCl<SUB>2</SUB>, Cd)-induced liver toxicity in rats. To induce acute toxicity, Cd (4 mg/kg body weight) was dissolved in normal saline and intravenously (i.v.) injected into rats. The rats then received either a vehicle or licorice water extract (50, 100 mg/kg/day) for 3 days, and were subsequently exposed to a single injection of Cd 24 h after the last licorice/vehicle treatment. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) were significantly increased by Cd treatment. In contrast, pretreatment with licorice reduced ALT, AST and LDH. In histopathological analysis, licorice decreased the central necrosis around central veins, the peripheral hemorrhage around portal triads, the percentage of degenerative hepatic regions (%/mm<sup>2</sup> hepatic parenchyma) and the number of degenerative hepatic cells (<I>N</I>/100 hepatic cells). Licorice also inhibited the increment of Bad (a BH3 domain-containing protein) translocation by Cd in liver cells. These results demonstrate that licorice could have a hepatoprotective effect by inhibiting the translocation of Bad to the mitochondria in Cd-intoxificated rats.</p>
]]></description>
<dc:creator><![CDATA[Lee, J. R., Park, S. J., Lee, H.-S., Jee, S. Y., Seo, J., Kwon, Y. K., Kwon, T. K., Kim, S. C.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem078</dc:identifier>
<dc:title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>201</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>195</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1">
<title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1</link>
<description><![CDATA[
<p>C<I>entella asiatica</I> (CeA) is a creeping herb, growing in moist places in India and other Asian Countries. Ayurvedic system of medicine, an alternate system of medicine in India, uses leaves of CeA for memory enhancement. Here, we have investigated the role of CeA fresh leaf juice treatment during growth spurt period of rats on dendritic morphology of amygdaloid neurons, one of the regions concerned with learning and memory. The present study was conducted on neonatal rat pups. The rat pups (7-days-old) were fed with 2, 4 and 6 ml/kg body of fresh leaf juice of CeA for 2, 4 and 6 weeks. After the treatment period, the rats were killed, brains removed and amygdaloid neurons impregnated with Silver nitrate (Golgi staining). Amygdaloid neurons were traced using camera lucida and dendritic branching points (a measure of dendritic arborization) and intersections (a measure dendritic length) quantified. These data were compared with those of age-matched control rats. The results showed a significant increase in dendritic length (intersections) and dendritic branching points along the length of dendrites of the amygdaloid neurons of rats treated with 4 and 6 ml/kg body weight/day of CeA for longer periods of time (i.e. 4 and 6 weeks). We conclude that constituents/active principles present in CeA fresh leaf juice has neuronal dendritic growth stimulating property; hence it can be used for enhancing neuronal dendrites in stress and other neurodegenerative and memory disorders.</p>
]]></description>
<dc:creator><![CDATA[Mohandas Rao, K. G., Muddanna Rao, S., Gurumadhva Rao, S.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem079</dc:identifier>
<dc:title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>210</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>203</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1">
<title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1</link>
<description><![CDATA[
<p>Tibetan medicated-bath therapy has been applied to patients with rheumatoid arthritis for centuries. However, the detailed action mechanism of Tibetan medicated-bath therapy on the morphology and function of joints remains unknown. We designed our investigation to evaluate the efficacy of Tibetan medicated-bath therapy on adjuvant arthritis (AA) of rats in comparison with water-bath and dexamethasone administration. AA was induced by intradermal injection of <I>Mycobacterium butyricum</I> suspended in sterile mineral oil. The control animals were similarly injected with sterile vehicle. Eight days after injection, rats were treated with fresh-water bath, Tibetan medicated-bath (40&deg;C, 15 min) or intramuscular injection with dexamethasone for 21 consecutive days after which we evaluated the severity of arthritis visually and microscopically and measured serum interleukin (IL)-6 and tumor necrosis factor (TNF)- levels. While arthritis did not significantly change after water-bath treatment, the Tibetan medicated-bath and dexamethasone groups showed diminished joint swelling and alleviation of, inflammatory cell infiltration and the destruction of bone and cartilage. Serum IL-6 and TNF- levels significantly decreased. Our results demonstrated that Tibetan medicated-bath therapy exerted a reliable effect on rat adjuvant arthritis, which may be involved in the inflammatory cytokines, IL-6 and TNF-. Our data provide evidence for clinical use of Tibetan-medicated bath therapy for arthritis patients.</p>
]]></description>
<dc:creator><![CDATA[Chen, H., Shoumura, S., Emura, S., Isono, H.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem083</dc:identifier>
<dc:title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>217</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>211</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1">
<title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1</link>
<description><![CDATA[
<p>Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular diseases. Root of <I>Asparagus racemosus</I> (AR) is widely used in Ayurvedic system of medicine in India and is known for its steroidal saponin content. This study was designed to investigate the hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholesteremic animals. Normal and hypercholesteremic male albino rats were administered with root powder of AR (5 and 10 g% dose levels) along with normal and hypercholesteremic diets, respectively, for a duration of 4 weeks. Plasma and hepatic lipid profiles, fecal sterol, bile acid excretion and hepatic antioxidant activity were assessed. Inclusion of AR root powder in diet, resulted in a dose-dependant reduction in plasma and hepatic lipid profiles, increased fecal excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA reductase activity and bile acid content in hypercholesteremic rats. Further, AR root also improved the hepatic antioxidant status (catalase, SOD and ascorbic acid levels). No significant changes in lipid and antioxidant profiles occurred in the normocholesteremic rats administered with AR root powder. AR root appeared to be useful as a dietary supplement that offers a protection against hyperlipidemia/hypercholesteremia in hypercholesteremic animals. The results of the present study indicate that the potent therapeutic phyto-components present in AR root i.e. phytosterols, saponins, polyphenols, flavonoids and ascorbic acid, could be responsible for increased bile acid production, elimination of excess cholesterol and elevation of hepatic antioxidant status in hypercholesteremic conditions.</p>
]]></description>
<dc:creator><![CDATA[Visavadiya, N. P., Narasimhacharya, A. V. R. L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem091</dc:identifier>
<dc:title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>226</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>219</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1">
<title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1</link>
<description><![CDATA[
<p>The antioxidant activities of crude extract of <I>Phaulopsis fascisepala</I> leaf were evaluated and compared with -tocopherol and BHT as synthetic antioxidants and ascorbic acid as natural-based antioxidant. <I>In vitro</I>, we studied its antioxidative activities, radical-scavenging effects, Fe<sup>2+</sup>-chelating ability and reducing power. The total phenolic content was determined and expressed in gallic acid equivalent. The extract showed variable activities in all of these <I>in vitro</I> tests. The antioxidant effect of <I>P. fascisepala</I> was strongly dose dependent, increased with increasing leaf extract dose and then leveled off with further increase in extract dose. Compared to other antioxidants used in the study, -Tocopherol, ascorbic acid and BHT, <I>P. fascisepala</I> leaf extract showed less scavenging effect on ,,-diphenyl-&beta;-picrylhydrazyl (DPPH) radical and less reducing power on Fe<sup>3+</sup>/ferricyanide complex but better Fe<sup>2+</sup>-chelating ability. These results revealed the <I>in vitro</I> antioxidant activity of <I>P</I>. <I>fascisepala.</I> Further investigations are necessary to verify these activities <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Adesegun, S. A., Fajana, A., Orabueze, C. I., Coker, H. A. B.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem098</dc:identifier>
<dc:title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>231</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1">
<title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1</link>
<description><![CDATA[
<p>The role of abrin, a toxic lectin isolated from seeds of <I>Abrus precatorius</I> Linn in inducing apoptosis in murine Dalton's Lymphoma Ascites (DLA) cells was evaluated. Abrin when incubated at the concentration of 10 ng per million DLA cells could bring about cell death as typical morphological changes with apoptosis. However, necrotic cell death dominated when a higher dose of abrin was used. DNA samples, isolated from DLA cells treated with abrin showed fragmentation. Abrin brought about induction of apoptosis by stimulating the expression of pro-apoptotic Caspase-3, at the same time blocking the expression of Bcl-2, which is an anti apoptotic gene. However, the expression of tumor suppressor gene p53 has not been observed in control and abrin-treated DLA cells. Results suggested that abrin effectively induced apoptotic changes in the tumor cells that led to cellular death.</p>
]]></description>
<dc:creator><![CDATA[Ramnath, V., Rekha, P. S., Kuttan, G., Kuttan, R.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem099</dc:identifier>
<dc:title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>238</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>233</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1">
<title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1</link>
<description><![CDATA[
<p>Using an adjuvant-induced arthritis rat model, we investigated the effects of a lipid extract of <I>Perna canaliculus</I> (Lyprinol&reg;) on pain. Radiological examinations, as well as levels of pro- and anti-inflammatory (AI) cytokines, were measured aiming to provide independent objective data to the pain controlling investigation. We confirmed the ability of Lyprinol&reg; to control pain at the initial phase of its administration; with similar efficacy to that observed with Naproxen. The pain scores slowly increased again in the group of rats treated with Lyprinol&reg; after day 9&ndash;14. The Naproxen-treated rats remained pain-free while treated. Both Naproxen and Lyprinol&reg; decreased the levels of the pro-inflammatory cytokines TNF- and IFN-, and increased that of IL-10. Extra-virgin olive oil was ineffective on cytokine secretion. Rats treated with Lyprinol&reg; were apparently cured after 1 year. This study confirms the AI efficacy of this lipid extract of <I>P. canaliculus</I>, its initial analgesic effect, its perfect tolerance and its long-term healing properties.</p>
]]></description>
<dc:creator><![CDATA[Lee, C.-H., Lum, J. H.-K., Ng, C. K.-C., McKay, J., Butt, Y. K.-C., Wong, M.-S., Lo, S. C.-L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem100</dc:identifier>
<dc:title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>245</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>239</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1">
<title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to investigate the efficacy of four different Japanese and Chinese herbal prescriptions, Ren-Shen-Yang-Rong-Tang (Ninjin&rsquo;yoeito, NYT), Chai-Hu-Gui-Zhi-Gan-Jiang-Tang (Saikokeishikankyoto, SKKT), Si-Jun-Zi-Tang (Shikunshito, SKT) and Si-Wu-Tang (Shimotsuto, SMT), which are traditionally used for anemia and fatigue, against hematotoxicity in mice treated with 5-fluorouracil (5-FU). NYT 1&ndash;100 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup> injected orally for 7 consecutive days before and after 5-FU injection significantly suppressed reductions in red blood cell, white blood cell and platelet counts in peripheral blood, and accelerated their recovery. Administration of SKKT also produced a slight but significant improvement in 5-FU-induced erythrocytopenia, whereas SMT and SKT could not prevent anemia. Oral injection of NYT also inhibited 5-FU-induced decreases in peripheral reticulocyte and bone marrow cell counts on day 10, and markedly hastened their recovery on day 20, in a dose-dependent manner. Erythroid progenitor colonies, such as colony forming units-erythroid and burst forming units-erythroid, formed by marrow cells from mice treated with 5-FU were significantly increased by oral administration of NYT. These findings suggest that NYT has the potential to protect against hematotoxicity, and also has hematopoietic activity, through stimulation of immature erythroid progenitor cell differentiation.</p>
]]></description>
<dc:creator><![CDATA[Takano, F., Ohta, Y., Tanaka, T., Sasaki, K., Kobayashi, K., Takahashi, T., Yahagi, N., Yoshizaki, F., Fushiya, S., Ohta, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem080</dc:identifier>
<dc:title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>256</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>247</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1">
<title><![CDATA[Dynamized Preparations in Cell Culture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1</link>
<description><![CDATA[
<p>Although reports on the efficacy of homeopathic medicines in animal models are limited, there are even fewer reports on the <I>in vitro</I> action of these dynamized preparations. We have evaluated the cytotoxic activity of 30C and 200C potencies of ten dynamized medicines against Dalton's Lymphoma Ascites, Ehrlich's Ascites Carcinoma, lung fibroblast (L929) and Chinese Hamster Ovary (CHO) cell lines and compared activity with their mother tinctures during short-term and long-term cell culture. The effect of dynamized medicines to induce apoptosis was also evaluated and we studied how dynamized medicines affected genes expressed during apoptosis. Mother tinctures as well as some dynamized medicines showed significant cytotoxicity to cells during short and long-term incubation. Potentiated alcohol control did not produce any cytotoxicity at concentrations studied. The dynamized medicines were found to inhibit CHO cell colony formation and thymidine uptake in L929 cells and those of <I>Thuja</I>, <I>Hydrastis</I> and <I>Carcinosinum</I> were found to induce apoptosis in DLA cells. Moreover, dynamized Carcinosinum was found to induce the expression of p53 while dynamized Thuja produced characteristic laddering pattern in agarose gel electrophoresis of DNA. These results indicate that dynamized medicines possess cytotoxic as well as apoptosis-inducing properties.</p>
]]></description>
<dc:creator><![CDATA[Sunila, E. S., Kuttan, R., Preethi, K. C., Kuttan, G.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem082</dc:identifier>
<dc:title><![CDATA[Dynamized Preparations in Cell Culture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>263</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>257</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1">
<title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1</link>
<description><![CDATA[
<p>Traditional Chinese Medicine practitioners consider that chronic fatigue reflects a disharmony and depletion in the supply of <I>qi</I> in the body. Qigong is one of the traditional complementary interventions used to strengthen <I>qi</I> through self-practice, and to manage the state of <I>qi</I> to prevent and cure disease. The aim of this study is to assess whether qigong could be used to manage the symptoms of chronic fatigue. Eighteen Caucasian, British female participants were recruited, taught a qigong routine during weekly classes over 6 months, and asked to practice it daily for 15 min. Participants completed the core set of the RAND Medical Outcomes Study questionnaire (RAND MOS) and a sleep diary during the 2-week baseline control period, and at 3 and 6 months following the start of the trial. The qigong intervention resulted in significant changes in sleep rate score and in the following subscales of the RAND MOS: SF36 Vitality, Sleep Problems, Social Activity, Social Activity Limitation due to Health, Health Distress, Mental Health Index and Psychological Well-being. Qigong seems to improve factors related to chronic fatigue such as sleep, pain, mental attitude and general mobility after 3 and 6 months. Qigong's positive effects indicate that it represents a potentially safe method of treatment for chronic fatigued patients. However, we cannot completely discount the possible influence of placebo effects, and more objective clinical measures are needed to reproduce our findings with long-term follow-up in a randomized, controlled study involving a larger number of subjects.</p>
]]></description>
<dc:creator><![CDATA[Craske, N. J. M., Turner, W., Zammit-Maempe, J., Lee, M. S.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem088</dc:identifier>
<dc:title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>270</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>265</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1">
<title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1</link>
<description><![CDATA[
<p>Although there are many clinical programs designed to bring humor into pediatric hospitals, there has been very little research with children or adolescents concerning the specific utility of humor for children undergoing stressful or painful procedures. Rx Laughter<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP>, a non-profit organization interested in the use of humor for healing, collaborated with UCLA to collect preliminary data on a sample of 18 children aged 7&ndash;16 years. Participants watched humorous video-tapes before, during and after a standardized pain task that involved placing a hand in cold water. Pain appraisal (ratings of pain severity) and pain tolerance (submersion time) were recorded and examined in relation to humor indicators (number of laughs/smiles during each video and child ratings of how funny the video was). Whereas humor indicators were not significantly associated with pain appraisal or tolerance, the group demonstrated significantly greater pain tolerance while viewing funny videos than when viewing the videos immediately before or after the cold-water task. The results suggest that humorous distraction is useful to help children and adolescents tolerate painful procedures. Further study is indicated to explore the specific mechanism of this benefit.</p>
]]></description>
<dc:creator><![CDATA[Stuber, M., Hilber, S. D., Mintzer, L. L., Castaneda, M., Glover, D., Zeltzer, L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem097</dc:identifier>
<dc:title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>276</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>271</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1">
<title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1</link>
<description><![CDATA[
<p>Two consecutive conferences on &lsquo;Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine&rsquo; were held in Xinjiang Medical University on July 3 and Kanazawa Medical University on October 6, 2007. The Vice president Halmurat Upur presided over the meeting and gave congratulatory address on holding of the conference. In order to understand mutually and discuss the possibility of the Uighur Medicine as CAM and the situation of medicine in the global sense, specialist scholars of Traditional Uighur Medicine and postgraduates attended this conference. In the meeting of the CAM, the achievements on the research of Traditional Uighur Medicine were exchanged and warmly discussed. Presentations were made in the consecutive conference.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Yamaguchi, N.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen012</dc:identifier>
<dc:title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>278</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>277</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1">
<title><![CDATA[eCAM: Clinical Analyses and Increasing Visibility]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep008</dc:identifier>
<dc:title><![CDATA[eCAM: Clinical Analyses and Increasing Visibility]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>2</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1">
<title><![CDATA[Dysautonomia, A Heuristic Approach to a Revised Model for Etiology of Disease]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1</link>
<description><![CDATA[
<p>Dysautonomia refers to a disease where the autonomic nervous system is dysfunctional. This may be a central control mechanism, as in genetically determined familial dysautonomia (Riley-Day Syndrome), or peripherally in the distribution of the sympathetic and parasympathetic systems. There are multiple reports of a number of different diseases associated with dysautonomia. The etiology of this association has never been explained. There are also multiple publications on dysautonomia associated with specific non-caloric nutritional deficiencies. Beriberi is the prototype of autonomic dysfunction. It is the best known nutritional deficiency disease caused by an imbalance between ingested calories and the vitamins required for their oxidation, particularly thiamin. Long thought to be abolished in modern medical thinking, there are occasional isolated reports of the full-blown disease in developed Western cultures.</p>
<p>Apart from genetically and epigenetically determined disease, evidence is presented that marginal high calorie malnutrition, particularly with reference to simple carbohydrates, is responsible for widespread dysautonomia. The brain and heart are the organs that have a fast rate of oxidative metabolism and are affected early by any mechanism that reduces oxidative efficiency. It is hypothesized that this results in a chaotic state of the hypothalamic/autonomic/endocrine axis. Due to the lack of adequate automatic controls, this may be responsible in some cases for breakdown of organ systems through long-standing energy deficiency, thus leading eventually to organic disease.</p>
]]></description>
<dc:creator><![CDATA[Lonsdale, D.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem064</dc:identifier>
<dc:title><![CDATA[Dysautonomia, A Heuristic Approach to a Revised Model for Etiology of Disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>10</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1">
<title><![CDATA[Analgesic Action of Acupuncture and Moxibustion: A Review of Unique Approaches in Japan]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1</link>
<description><![CDATA[
<p>The mechanism of acupuncture analgesia (AA) is one of the most widely researched topics in complementary and alternative medicine (CAM) based on modern medical methodology. Endogenous opioid-mediated mechanisms of acupuncture have been well established since the 1970s. In this review, we have covered the progress of AA research by Japanese investigators. In particular, we have reviewed the physiological basis of analgesic effects induced by acupuncture and moxibustion, including the actions of endogenous opioid and diffuse noxious inhibitory controls (DNICs), and the afferent fibers participating in acupuncture and moxibustion stimuli are discussed.</p>
]]></description>
<dc:creator><![CDATA[Okada, K., Kawakita, K.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem090</dc:identifier>
<dc:title><![CDATA[Analgesic Action of Acupuncture and Moxibustion: A Review of Unique Approaches in Japan]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>17</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>11</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1">
<title><![CDATA[Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1</link>
<description><![CDATA[
<p>In Europe many cancer patients use complementary therapies, particularly mistletoe. Only a few controlled clinical trials have been performed with the mistletoe preparation Iscador as a complementary treatment for cancer, many of them with medium to low quality due to methodological shortcomings. Reasons for some quality concerns, particularly discontinuation of treatment and/or participation and premature termination are analyzed. Analysis is based on controlled clinical trials dealing with Iscador. Data stem from the archive of published and ongoing research of the &laquo;Verein f&uuml;r Krebsforschung&raquo; (Society for Cancer Research) in Arlesheim, Switzerland. Controlled clinical studies with cancer patients that were started after 01.01.1990 or were not completed by then have been evaluated. Fifty-six controlled studies are documented, 24 of them randomized and 32 non-randomized. Nine of the randomized studies were done by matched-pair design, the others by conventional parallel group design; six of the last were terminated prematurely primarily for slow recruitment due to patient preferences and compliance of physicians. Patient and physician preference seem to be important factors limiting recruitment for randomized trials and hence implementation. This adds to the overall unwillingness of participation by patients with serious diseases. A well-balanced mix of designs using different research methods and outcomes is suggested combined with analyses, in countries where mistletoe therapy in general or Iscador in particular is unknown or not available.</p>
]]></description>
<dc:creator><![CDATA[Ziegler, R.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem121</dc:identifier>
<dc:title><![CDATA[Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>30</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>19</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1">
<title><![CDATA[Prospective Tests on Biological Models of Acupuncture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1</link>
<description><![CDATA[
<p>The biological effects of acupuncture include the regulation of a variety of neurohumoral factors and growth control factors. In science, models or hypotheses with confirmed predictions are considered more convincing than models solely based on retrospective explanations. Literature review showed that two biological models of acupuncture have been prospectively tested with independently confirmed predictions: The neurophysiology model on the long-term effects of acupuncture emphasizes the trophic and anti-inflammatory effects of acupuncture. Its prediction on the peripheral effect of endorphin in acupuncture has been confirmed. The growth control model encompasses the neurophysiology model and suggests that a macroscopic growth control system originates from a network of organizers in embryogenesis. The activity of the growth control system is important in the formation, maintenance and regulation of all the physiological systems. Several phenomena of acupuncture such as the distribution of auricular acupuncture points, the long-term effects of acupuncture and the effect of multimodal non-specific stimulation at acupuncture points are consistent with the growth control model. The following predictions of the growth control model have been independently confirmed by research results in both acupuncture and conventional biomedical sciences: (i) Acupuncture has extensive growth control effects. (ii) Singular point and separatrix exist in morphogenesis. (iii) Organizers have high electric conductance, high current density and high density of gap junctions. (iv) A high density of gap junctions is distributed as separatrices or boundaries at body surface after early embryogenesis. (v) Many acupuncture points are located at transition points or boundaries between different body domains or muscles, coinciding with the connective tissue planes. (vi) Some morphogens and organizers continue to function after embryogenesis. Current acupuncture research suggests a convergence of the neurophysiology model, the connective tissue model and the growth control model. The growth control model of acupuncture set the first example of a biological model in integrative medicine with significant prediction power.</p>
]]></description>
<dc:creator><![CDATA[Shang, C.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem122</dc:identifier>
<dc:title><![CDATA[Prospective Tests on Biological Models of Acupuncture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>39</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>31</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1">
<title><![CDATA[Randomized Clinical Trials on Acupuncture in Korean Literature: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1</link>
<description><![CDATA[
<p>The aim of this systematic review was to summarize randomized clinical trials (RCTs) assessing the effectiveness of acupuncture as published in Korean literature. Systematic searches were conducted on eight Korean medical databases. Manual searches were also conducted through eight major Korean medical journals. The methodological quality was assessed using a Jadad score. Studies evaluating needle acupuncture or auricular acupuncture (AA) with or without electrical stimulation were considered if they were sham or placebo-controlled or controlled against a comparative intervention. We also excluded acupuncture as an adjuvant to other treatments and other forms of acupuncture were excluded. Seven hundred and nine possibly relevant studies were identified and 10 RCTs were included. The methodological quality of the trials was generally poor. Manual acupuncture was compared to placebo acupuncture in four studies of patients with chronic low back pain, shoulder pain, premenstrual syndrome and allergic rhinitis. Three studies tested AA (two trials) and electroacupuncture (one trial) against no treatment, while three trials compared acupuncture with other active therapeutic controls. The methodological limitations of the included trials make their contribution to the current clinical evidence of acupuncture somewhat limited. The trial for premenstrual syndrome, shoulder pain and chronic low back pain added a limited contribution among those included RCTs. However, well-designed RCTs of acupuncture with a rigorous methodology are in progress or have been completed in Korea and will contribute to establish or contribute to the current progress of research in this field.</p>
]]></description>
<dc:creator><![CDATA[Kong, J. C., Lee, M. S., Shin, B.-C.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem130</dc:identifier>
<dc:title><![CDATA[Randomized Clinical Trials on Acupuncture in Korean Literature: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>48</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>41</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1">
<title><![CDATA[Between-Groups Study Designs Demand Between-Groups Analyses: A Response to Hernandez-Reif, Shor-Posner, Baez, Soto, Mendoza, Castillo, Quintero, Perez, and Zhang]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1</link>
<description><![CDATA[
<p>The most recent massage therapy (MT) study by Hernandez-Reif <I>et al.</I> displays flaws persistent in this area of research that are attributable to MT researchers&rsquo; frequent mistake of using within-group analyses of dependent variables in studies that are purported to be randomized control trials. This practise violates the logic of using randomization to create treatment and control groups, and thereby fails to control for the validity threats of spontaneous remission, placebo effects, and statistical regression. The result is that a clear understanding of what MT can and cannot do is seriously hampered.</p>
]]></description>
<dc:creator><![CDATA[Moyer, C. A.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem164</dc:identifier>
<dc:title><![CDATA[Between-Groups Study Designs Demand Between-Groups Analyses: A Response to Hernandez-Reif, Shor-Posner, Baez, Soto, Mendoza, Castillo, Quintero, Perez, and Zhang]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>50</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>49</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1">
<title><![CDATA[Neurochemical Mechanism of Electroacupuncture: Anti-injury Effect on Cerebral Function after Focal Cerebral Ischemia in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1</link>
<description><![CDATA[
<p>We explored the neurochemical mechanism of electroacupuncture's (EA) protective effect on brain function in focal cerebral ischemia rats, using cerebral ischemia/reperfusion rats established by the middle cerebral artery occlusion (MCAO) method. Adult male Sprague&ndash;Dawley rats were randomly divided into four groups: Sham, Sham+EA, MCAO and MCAO+EA. The rats in Sham+EA and MCAO+EA were accepted EA treatment at &lsquo;GV26&rsquo; and &lsquo;GV20&rsquo; acupoints for 30 min. Electric stimulation was produced by a G-6805 generator and neurological deficit scores were recorded. Mitochondria respiratory function and the activities of respiratory enzymes were measured by a computer-aided Clark oxygen electrode system. Results showed that EA treatment might reduce the neurological deficit score, and significantly improve respiratory control ratio (RCR), the index of mitochondrial respiratory function, and increase the activities of succinic dehydrogenase, NADH dehydrogenase and cytochrome C oxidase in the MCAO rats. Results suggest that EA might markedly decrease the neurological deficit score, promote the activities of respiratory enzymes and reduce the generation of reactive oxygen species (ROS), resulting in improvement of respiratory chain function and anti-oxidative capability of brain tissues in the infarct penumbra zone. This be a mechanism of EA's anti-injury effect on brain function in MCAO rats.</p>
]]></description>
<dc:creator><![CDATA[Zhong, S., Li, Z., Huan, L., Chen, B.-Y.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem062</dc:identifier>
<dc:title><![CDATA[Neurochemical Mechanism of Electroacupuncture: Anti-injury Effect on Cerebral Function after Focal Cerebral Ischemia in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>56</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>51</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1">
<title><![CDATA[Screening of Bioactive Compounds from Moutan Cortex and Their Anti-Inflammatory Activities in Rat Synoviocytes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1</link>
<description><![CDATA[
<p>Moutan Cortex, a widely used traditional Chinese medicine for the treatment of various diseases, is the root bark of <I>Paeonia suffruticosa Andrews</I> (Paeoniaceae). Most of the pharmacological investigations of Moutan Cortex have been addressed to its central nervous system activities, anti-oxidative and sedative actions. Otherwise, there are few reports about the active compounds with anti-inflammatory activity of Moutan Cortex. The aim of the present study was to screen and identify bioactive compounds with anti-inflammatory effect from Moutan Cortex. With the aid of preparative high performance liquid chromatography (HPLC) technique, ethyl acetate and ethanol extract of Moutan Cortex were isolated into twenty-two fractions. Bioactivities of these fractions were evaluated by measuring expression of tumor necrosis factor- (TNF-) in rat synoviocytes subjected to interleukin-1&beta; (IL-1&beta;). Eight compounds were isolated from six active fractions and identified by HPLC/MS<sup>n</sup>. Purified compounds, paeoniflorin, paeonol and pentagalloylglucose resulted in dose-dependent inhibition of TNF- synthesis and IL-6 production in synoviocytes treated with proinflammatory mediator. These results suggested that paeonol, paeoniflorin, glycosides and pentagalloylglucose contribute to the anti-inflammatory effect of Moutan Cortex.</p>
]]></description>
<dc:creator><![CDATA[Wu, M., Gu, Z.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem066</dc:identifier>
<dc:title><![CDATA[Screening of Bioactive Compounds from Moutan Cortex and Their Anti-Inflammatory Activities in Rat Synoviocytes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>63</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>57</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1">
<title><![CDATA[Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1</link>
<description><![CDATA[
<p>To examine if a potentized homeopathic drug, Natrum Sulphuricum 200 (Nat Sulph-200) has protective potentials against hepatocarcinogenesis, liver tumors were induced in mice through chronic feeding of <I>P</I>-dimethylaminoazobenzene (p-DAB; initiator of hepatocarcinogenesis) and phenobarbital (PB; promoter). Mice were divided into five sub-groups: fed normal low protein diet (Gr. I, normal control); fed normal low protein plus alcohol-200 (vehicle of the homeopathic remedy) (Gr. II); fed diet mixed with 0.06% p-DAB plus 0.05% PB (Gr. III); fed diet and carcinogens like Gr.III, plus alcohol 200 (positive control for drug fed mice) (Gr. IV) and fed diet and carcinogens like Gr. III, plus Natrum Sulphuiricum-200 (Gr. V; drug fed). Mice were sacrificed at day 7, 15, 30, 60, 90 and day 120 for study of cytogenetical endpoints like chromosome aberrations (CA), micronuclei (MN), mitotic index (MI) and sperm head anomaly (SHA) and biochemical toxicity parameters like aspartate amino transferase (AST), alanine amino transferase (ALT), acid (AcP) and alkaline (AlkP) phosphatases, lipid peroxidation (LPO) and reduced glutathione (GSH) content. Less number of liver tumors were observed in Gr. V (drug fed) mice. Administration of Nat Sulph 200 reduced genomic damage, activities of AcP, AlkP, AST, ALT, LPO and increased GSH content. Therefore, independent replication of the study by others is encouraged.</p>
]]></description>
<dc:creator><![CDATA[Bhattacharjee, N., Pathak, S., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem067</dc:identifier>
<dc:title><![CDATA[Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>75</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>65</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1">
<title><![CDATA[Acupuncture on the Blood Flow of Various Organs Measured Simultaneously by Colored Microspheres in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1</link>
<description><![CDATA[
<p>We examined how acupuncture affected the blood flow of muscle, kidney, stomach, small intestine, brain, lung, heart, spleen and liver. Wistar rats anesthetized with urethane (<I>n</I> = 27) were allocated into the control (<I>n</I> = 10), ST-7 (Hsia-Kuan, <I>n</I> = 10) and LI-4 (Hoku, <I>n</I> = 7) groups. To measure organ blood flow, colored microspheres (CMS) were injected through a catheter positioned in the left ventricle and blood samples were drawn from the femoral artery. Yellow CMS (3.6&ndash;4.2 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup>) and blue CMS (6.0&ndash;6.9 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup>) were injected at intervals of about 30 min. An acupuncture needle ( 340 &micro;m) was inserted into the left ST-7 point (left masseter muscle) or the right LI-4 point after the first sampling and left for about 30 min (10 twists at 1 Hz, 2-min intervals). The mean blood flow of nine organs varied widely from 4.03 to 0.20 (ml/min/g). Acupuncture to the ST-7 produced significant changes of the blood flow (percentage change from baseline) in the muscle, kidney, brain and heart (<I>P</I> &lt; 0.05, versus control), but those of LI-4 were not significant. The blood flow of the left masseter muscle after acupuncture to ST-7 (left masseter muscle) tended to increase (<I>P</I> = 0.08). Changes in blood pressure during the experimental periods were almost similar among these three groups. Acupuncture stimulation increases the blood flow of several organs by modulating the central circulatory systems, and the effects differed with sites of stimulation.</p>
]]></description>
<dc:creator><![CDATA[Tsuru, H., Kawakita, K.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem068</dc:identifier>
<dc:title><![CDATA[Acupuncture on the Blood Flow of Various Organs Measured Simultaneously by Colored Microspheres in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>83</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>77</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1">
<title><![CDATA[Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1</link>
<description><![CDATA[
<p>Substantial evidence suggests that the behavioral and reinforcing effects of cocaine can be mediated by the central dopaminergic systems. Repeated injections of cocaine produce an increase in locomotor activity and the expression of tyrosine hydroxylase (TH) in the main dopaminergic areas. Protoberberine alkaloids affect neuronal functions. <I>Coptidis rhizoma</I> (CR) and its main compound, berberine (BER) reduced the dopamine content in the central nervous system. In order to investigate the effects of CR or BER on the repeated cocaine-induced neuronal and behavioral alterations, we examined the influence of CR or BER on the repeated cocaine-induced locomotor activity and the expression of TH in the brain by using immunohistochemistry. Male SD rats were given repeated injections of saline or cocaine hydrochloride (15 mg/kg, i.p. for 10 consecutive days) followed by one challenge injection on the 4th day after the last daily injection. Cocaine challenge (15 mg/kg, i.p) produced a larger increase in locomotor activity and expression of TH in the central dopaminergic areas. Pretreatment with CR (50, 100, 200 and 400 mg/kg, p.o.) and BER (200 mg/kg, p.o.) 30 min before the daily injections of cocaine significantly inhibited the cocaine-induced locomotor activity as well as TH expression in the central dopaminergic areas. Our data demonstrate that the inhibitory effects of CR and BER on the repeated cocaine-induced locomotor activity were closely associated with the reduction of dopamine biosynthesis and post-synaptic neuronal activity. These results suggest that CR and BER may be effective for inhibiting the behavioral effects of cocaine by possibly modulating the central dopaminergic system.</p>
]]></description>
<dc:creator><![CDATA[Lee, B., Yang, C. H., Hahm, D.-H., Choe, E. S., Lee, H.-J., Pyun, K.-H., Shim, I.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem070</dc:identifier>
<dc:title><![CDATA[Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>90</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>85</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1">
<title><![CDATA[Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1</link>
<description><![CDATA[
<p>The herb feverfew is a folk remedy for various symptoms including inflammation. Inflammation has recently been implicated in the genesis of many diseases including cancers, atherosclerosis and rheumatoid arthritis. The mechanisms of action of feverfew in the human body are largely unknown. To determine the cellular targets of feverfew extracts, we have utilized oligo microarrays to study the gene expression profiles elicited by feverfew extracts in human monocytic THP-1 cells. We have identified 400 genes that are consistently regulated by feverfew extracts. Most of the genes are involved in cellular metabolism. However, the genes undergoing the highest degree of change by feverfew treatment are involved in other pathways including chemokine function, water homeostasis and heme-mediated signaling. Our results also suggest that feverfew extracts effectively reduce Lipopolysaccharides (LPS)-mediated TNF- and CCL2 (MCP-1) releases by THP-1 cells. We hypothesize that feverfew components mediate metabolism, cell migration and cytokine production in human monocytes/macrophages.</p>
]]></description>
<dc:creator><![CDATA[Chen, C.-F., Cheng, C.-H.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem061</dc:identifier>
<dc:title><![CDATA[Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>98</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>91</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1">
<title><![CDATA[Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1</link>
<description><![CDATA[
<p>We conducted a systematic review to evaluate the efficacy and safety of Chinese herbal medicine (CHM) for dysfunctional uterine bleeding (DUB) by performing a meta-analysis. Randomized controlled trials (RCTs) or quasi-RCTs comparing CHM vs no treatment, placebo, conventional western medicine (CWM), or general non-specific surgical treatment for DUB were identified by electronic and manual searches. Trials of CHM treatments with CWM treatments were compared with CWM treatments alone. Jadad scale and allocation concealment were used to assess the quality of included studies. Four RCTs or quasi-RCTs involving 525 patients were included. The methodological quality was poor in all trials except one trial. No serious adverse events were reported in the included studies. With the lack of trials comparing CHM with no treatment or placebo, it is impossible to accurately evaluate the efficacy of CHM. However, CHM in these studies seem to show an encouraging comparative effectiveness with CWM. More RCTs with a higher quality are required.</p>
]]></description>
<dc:creator><![CDATA[Tu, X., Huang, G., Tan, S.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem063</dc:identifier>
<dc:title><![CDATA[Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>105</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>99</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1">
<title><![CDATA[Variation Analysis of Sphygmogram to Assess Cardiovascular System under Meditation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1</link>
<description><![CDATA[
<p>In this article, we studied how meditation affects the characteristics of the cardiovascular system, mainly based on blood pressure waveforms (BPW). Four parameters derived from BPW include the rising slope (<I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB>), normalized height of T wave (<I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB>), normalized height of <I>V</I><SUB>3</SUB> valley (<I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB>) and normalized height of D wave (<I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB>), where <I>t</I><SUB>1</SUB> and <I>h<SUB>i</SUB></I>, <I>i</I> = 1, ... ,5 are quantitative features of the BPW waveform pattern. A larger value of <I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB> reflects better heart ejection ability and aorta compliance. A larger value of <I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB> may infer an arterial system with good elasticity. The decrease (increase) of <I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB> parameter indicates the decrease (increase) of peripheral resistance of vessels. A larger value of <I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB> indicates better artery elasticity and aortic valve function. In comparison with the control group, Zen-meditation practitioners have more after-meditation <I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB>, <I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB> and <I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB> increase, with more <I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB> decrease, with statistical significance (<I>P</I> &lt; 0.05). The observation allows us to infer that Zen meditation may effectively improve relevant characteristics of the cardiovascular system.</p>
]]></description>
<dc:creator><![CDATA[Liu, C.-Y., Wei, C.-C., Lo, P.-C.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem065</dc:identifier>
<dc:title><![CDATA[Variation Analysis of Sphygmogram to Assess Cardiovascular System under Meditation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>112</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>107</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1">
<title><![CDATA[Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1</link>
<description><![CDATA[
<p>The antioxidant activity of four honey samples from different floral sources (Acacia, Coriander, Sider and Palm) were evaluated with three different assays; DPPH free radical scavenging assay, superoxide anion generated in xanthine&ndash;xanthine oxidase (XOD) system and low density lipoprotein (LDL) peroxidation assay. The dark Palm and Sider honeys had the highest antioxidant activity in the DPPH assay. But all the honey samples exhibited more or less the same highly significant antioxidant activity within the concentration of 1mg honey/1 ml in XOD system and LDL peroxidation assays. The chemical composition of these samples was investigated by GC/MS and HPLC analysis, 11 compounds being new to honey. The GC/MS revealed the presence of 90 compounds, mainly aliphatic acids (37 compounds), which represent 54.73, 8.72, 22.87 and 64.10% and phenolic acids (15 compound) 2.3, 1.02, 2.07 and 11.68% for Acacia, Coriander, Sider and Palm honeys. In HPLC analysis, 19 flavonoids were identified. Coriander and Sider honeys were characterized by the presence of large amounts of flavonoids.</p>
]]></description>
<dc:creator><![CDATA[Hegazi, A. G., Abd El-Hady, F. K.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem071</dc:identifier>
<dc:title><![CDATA[Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>121</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>113</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1">
<title><![CDATA[Anxiolytic Effect of Aromatherapy Massage in Patients with Breast Cancer]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1</link>
<description><![CDATA[
<p>We examined how aromatherapy massage influenced psychologic and immunologic parameters in 12 breast cancer patients in an open semi-comparative trial. We compared the results 1 month before aromatherapy massage as a waiting control period with those during aromatherapy massage treatment and 1 month after the completion of aromatherapy sessions. The patients received a 30 min aromatherapy massage twice a week for 4 weeks (eight times in total). The results showed that anxiety was reduced in one 30 min aromatherapy massage in State-Trait Anxiety Inventory (STAI) test and also reduced in eight sequential aromatherapy massage sessions in the Hospital Anxiety and Depression Scale (HADS) test. Our results further suggested that aromatherapy massage ameliorated the immunologic state. Further investigations are required to confirm the anxiolytic effect of aromatherapy in breast cancer patients.</p>
]]></description>
<dc:creator><![CDATA[Imanishi, J., Kuriyama, H., Shigemori, I., Watanabe, S., Aihara, Y., Kita, M., Sawai, K., Nakajima, H., Yoshida, N., Kunisawa, M., Kawase, M., Fukui, K.]]></dc:creator>
<dc:date>2009-02-17</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem073</dc:identifier>
<dc:title><![CDATA[Anxiolytic Effect of Aromatherapy Massage in Patients with Breast Cancer]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>128</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>123</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/365?rss=1">
<title><![CDATA[eCAM: An Emerging Linkage with Ethnopharmacology?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/365?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen073</dc:identifier>
<dc:title><![CDATA[eCAM: An Emerging Linkage with Ethnopharmacology?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>366</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>365</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/367?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/367?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen015</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>369</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>367</prism:startingPage>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/371?rss=1">
<title><![CDATA[A Review of CAM for Procedural Pain in Infancy: Part I. Sucrose and Non-nutritive Sucking]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/371?rss=1</link>
<description><![CDATA[
<p>There is increasing concern regarding the number of painful medical procedures that infants must undergo and the potential risks of alleviating infant pain with conventional pharmacologic agents. This article is Part I of a two-part series that aims to provide an overview of the literature on complementary and alternative (CAM) approaches for pain and distress related to medical procedures among infants up to six weeks of age. The focus of this article is a review of the empirical literature on sucrose with or without non-nutritive sucking (NNS) for procedural pain in infancy. Computerized databases were searched for relevant studies including prior reviews and primary trials. The most robust evidence was found for the analgesic effects of sucrose with or without NNS on minor procedural pain in healthy full-term infants. Despite some methodological weaknesses, the literature to date supports the use of sucrose, NNS and other sweetened solutions for the management of procedural pain in infancy.</p>
]]></description>
<dc:creator><![CDATA[Tsao, J. C. I., Evans, S., Meldrum, M., Altman, T., Zeltzer, L. K.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem084</dc:identifier>
<dc:title><![CDATA[A Review of CAM for Procedural Pain in Infancy: Part I. Sucrose and Non-nutritive Sucking]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>381</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>371</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/383?rss=1">
<title><![CDATA[Blinding Techniques in Randomized Controlled Trials of Laser Therapy: An Overview and Possible Solution]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/383?rss=1</link>
<description><![CDATA[
<p>Low-level laser therapy has evidence accumulating about its effectiveness in a variety of medical conditions. We reviewed 51 double blind randomized controlled trials (RCTs) of laser treatment. Analysis revealed 58% of trials showed benefit of laser over placebo. However, less than 5% of the trials had addressed beam disguise or allocation concealment in the laser machines used. Many of the trials used blinding methods that rely on staff cooperation and are therefore open to interference or bias. This indicates significant deficiencies in laser trial methodology. We report the development and preliminary testing of a novel laser machine that can blind both patient and operator to treatment allocation without staff participation. The new laser machine combines sealed preset and non-bypassable randomization codes, decoy lights and sound, and a conical perspex tip to overcome laser diode glow detection.</p>
]]></description>
<dc:creator><![CDATA[Relf, I., Chow, R., Pirotta, M.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem085</dc:identifier>
<dc:title><![CDATA[Blinding Techniques in Randomized Controlled Trials of Laser Therapy: An Overview and Possible Solution]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>389</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>383</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/391?rss=1">
<title><![CDATA[Safety of Acupuncture Practice in Japan: Patient Reactions, Therapist Negligence and Error Reduction Strategies]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/391?rss=1</link>
<description><![CDATA[
<p>Evidence-based approach on the safety of acupuncture had been lagging behind both in the West and the East, but reliable data based on some prospective surveys were published after the late 1990s. In the present article, we, focusing on &lsquo;Japanese acupuncture&rsquo;, review relevant case reports and prospective surveys on adverse events in Japan, assess the safety of acupuncture practice in this country, and suggest a strategy for reducing the therapists&rsquo; error. Based on the prospective surveys, it seems reasonable to suppose that serious adverse events are rare in standard practice by adequately trained acupuncturists, regardless of countries or modes of practice. Almost all of adverse reactions commonly seen in acupuncture practice&mdash;such as fatigue, drowsiness, aggravation, minor bleeding, pain on insertion and subcutaneous hemorrhage&mdash;are mild and transient, although we should be cautious of secondary injury following drowsiness and needle fainting. After demonstrating that acupuncture is inherently safe, we have been focusing on how to reduce the risk of negligence in Japan, as well as educating acupuncturists more about safe depth of insertion and infection control. Incident reporting and feedback system is a useful strategy for reducing therapist errors such as forgotten needles. For the benefit of acupuncture patients in Japan, it is important to establish mandatory postgraduate clinical training and continued education system.</p>
]]></description>
<dc:creator><![CDATA[Yamashita, H., Tsukayama, H.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem086</dc:identifier>
<dc:title><![CDATA[Safety of Acupuncture Practice in Japan: Patient Reactions, Therapist Negligence and Error Reduction Strategies]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>398</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>391</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/399?rss=1">
<title><![CDATA[A Review of CAM for Procedural Pain in Infancy: Part II. Other Interventions]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/399?rss=1</link>
<description><![CDATA[
<p>This article is the second in a two-part series reviewing the empirical evidence for complementary and alternative medicine (CAM) approaches for the management of pain related to medical procedures in infants up to 6 weeks of age. Part I of this series investigated the effects of sucrose with or without non-nutritive sucking (NNS). The present article examines other CAM interventions for procedural pain including music-based interventions, olfactory stimulation, kangaroo care and swaddling. Computerized databases were searched for relevant studies including prior reviews and primary trials. Preliminary support was revealed for the analgesic effects of the CAM modalities reviewed. However, the overall quality of the evidence for these approaches remains relatively weak. Additional well-designed trials incorporating rigorous methodology are required. Such investigations will assist in the development of evidence-based guidelines on the use of CAM interventions either alone or in concert with conventional approaches to provide safe, reliable analgesia for infant procedural pain.</p>
]]></description>
<dc:creator><![CDATA[Tsao, J. C. I., Evans, S., Meldrum, M., Altman, T., Zeltzer, L. K.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem089</dc:identifier>
<dc:title><![CDATA[A Review of CAM for Procedural Pain in Infancy: Part II. Other Interventions]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>407</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>399</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/409?rss=1">
<title><![CDATA[Divining integrative medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/409?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Stumpf, S. H., Shapiro, S. J., Hardy, M. L.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem104</dc:identifier>
<dc:title><![CDATA[Divining integrative medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>413</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>409</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/415?rss=1">
<title><![CDATA[Evidence-based Critical Evaluation of Glycemic Potential of Cynodon dactylon]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/415?rss=1</link>
<description><![CDATA[
<p>The present study is an extension of our previous work carried out on <I>Cynodon dactylon</I>. This study deals with the critical evaluation of glycemic potential of ethanolic extract of defatted <I>C. dactylon</I>. The doses of 250, 500 and 750 mg kg<sup>&ndash;1</sup> bw of the extract were administered orally to normal as well as Streptozotocin-induced diabetic rats to study its glycemic potential. The effect of repeated oral administration of the same doses of ethanolic extract was also studied on serum lipid profile of severely diabetic (SD) rats. The dose of 500 mg kg<sup>&ndash;1</sup> bw was identified as the most effective dose as it lowered the blood glucose levels of normal by 42.12% and of diabetic by 43.42% during fasting blood glucose (FBG) and glucose tolerance test respectively. The SD rats were also treated daily with this identified dose of 500 mg kg<sup>&ndash;1</sup> bw for 2 weeks and a significant reduction of 56.34% was observed in FBG level. Total cholesterol, low density lipoprotein and triglyceride levels were also decreased by 32.94, 64.06 and 48.46% respectively in SD rats whereas, cardioprotective high density lipoprotein increased by 16.45%. The reduced urine sugar level and increased body weight are additional advantages. These evidences clearly indicate that the ethanolic extract of defatted <I>C. dactylon</I> has high antidiabetic potential along with good hypolipidemic profile.</p>
]]></description>
<dc:creator><![CDATA[Singh, S. K., Rai, P. K., Jaiswal, D., Watal, G.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem044</dc:identifier>
<dc:title><![CDATA[Evidence-based Critical Evaluation of Glycemic Potential of Cynodon dactylon]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>420</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>415</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/421?rss=1">
<title><![CDATA[Maintaining A Physiological Blood Glucose Level with 'Glucolevel', A Combination of Four Anti-Diabetes Plants Used in the Traditional Arab Herbal Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/421?rss=1</link>
<description><![CDATA[
<p>Safety and anti-diabetic effects of Glucolevel, a mixture of dry extract of leaves of the <I>Juglans regia</I> L, <I>Olea europea</I> L, <I>Urtica dioica</I> L and <I>Atriplex halimus</I> L were evaluated using <I>in vivo</I> and <I>in vitro</I> test systems. No sign of toxic effects (using LDH assay) were seen in cultured human fibroblasts treated with increasing concentrations of Glucolevel. Similar observations were seen <I>in vivo</I> studies using rats (LD50: 25 g/kg). Anti-diabetic effects were evidenced by the augmentation of glucose uptake by yeast cells (2-folds higher) and by inhibition of glucose intestinal absorption (~49%) in a rat gut-segment. Furthermore, treatment with Glucolevel of Streptozotocin-induced diabetic rats for 2&ndash;3 weeks showed a significant reduction in glucose levels [above 400 &plusmn; 50 mg/dl to 210 &plusmn; 22 mg/dl (<I>P</I> &lt; 0.001)] and significantly improved sugar uptake during the glucose tolerance test, compared with positive control. In addition, glucose levels were tested in sixteen human volunteers, with the recent onset of type 2 diabetes mellitus, who received Glucolevel tablets 1 <FONT FACE="arial,helvetica">x</FONT> 3 daily for a period of 4 weeks. Within the first week of Glucolevel consumption, baseline glucose levels were significantly reduced from 290 &plusmn; 40 to 210 &plusmn; 20 mg/dl. At baseline, a subgroup of eleven of these subjects had glucose levels below 300 mg% and the other subgroup had levels &ge; 300 mg%. Clinically acceptable glucose levels were achieved during the 2&ndash;3 weeks of therapy in the former subgroup and during the 4th week of therapy in the latter subgroup. No side effect was reported. In addition, a significant reduction in hemoglobin A1C values (8.2 &plusmn; 1.03 to 6.9 &plusmn; 0.94) was found in six patients treated with Glucolevel. Results demonstrate safety, tolerability and efficacy of herbal combinations of four plants that seem to act differently but synergistically to regulate glucose-homeostasis.</p>
]]></description>
<dc:creator><![CDATA[Said, O., Fulder, S., Khalil, K., Azaizeh, H., Kassis, E., Saad, B.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem047</dc:identifier>
<dc:title><![CDATA[Maintaining A Physiological Blood Glucose Level with 'Glucolevel', A Combination of Four Anti-Diabetes Plants Used in the Traditional Arab Herbal Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>428</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>421</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/429?rss=1">
<title><![CDATA[Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/429?rss=1</link>
<description><![CDATA[
<p>Here, 45 Chinese herbs that regulate blood circulation were analyzed for antioxidant activity using the oxygen radical absorbance capacity (ORAC) assay. A recent publication by Ou <I>et al.</I> identified a close relationship between <I>in vitro</I> antioxidant activity and classification of Chinese herbs as <I>yin</I> or <I>yang</I>. The 45 Chinese herbs in this study could be assigned the traditional characteristics of natures (cold, cool, hot and warm), flavors (pungent, sweet, sour, bitter and salty) and functions (arresting bleeding, promoting blood flow to relieve stasis, nourishing blood and clearing away heat from blood). These characteristics are generalized according to the theory of <I>yin</I> and <I>yang</I>. We identified a broad range, 40&ndash;1990 &micro;mol Trolox Equivalent/g herbs, of antioxidant activity in water extracts. There was no significant correlation between ORAC values and natures or functions of the herbs. There was a significant relationship between flavors and ORAC values. Bitter and/or sour herbs had the highest ORAC values, pungent and/or sweet herbs the lowest. Other flavors had intermediate values. Flavors also correspond with the <I>yin/yang</I> relationship and our results are supportive of the earlier publication. We reported for the first time antioxidant properties of many Chinese herbs. High antioxidant herbs were identified as <I>Spatholobus suberectus</I> vine (1990 &micro;mol TE/g), <I>Sanguisorba officinalis</I> root (1940 &micro;mol TE/g), <I>Agrimonia pilosa</I> herb (1440 &micro;mol TE/g), <I>Artemisia anomala</I> herb (1400 &micro;mol TE/g), <I>Salvia miltiorrhiza</I> root (1320 &micro;mol TE/g) and <I>Nelembo nucifera</I> leaf (1300 &micro;mol TE/g). Antioxidant capacity appears to correlate with the flavors of herbs identified within the formal TCM classification system and may be a useful guide in describing their utility and biochemical mechanism of action.</p>
]]></description>
<dc:creator><![CDATA[Liao, H., Banbury, L. K., Leach, D. N.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem054</dc:identifier>
<dc:title><![CDATA[Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>434</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>429</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/435?rss=1">
<title><![CDATA[Brazilian Red Propolis--Chemical Composition and Botanical Origin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/435?rss=1</link>
<description><![CDATA[
<p>Propolis contains resinous substances collected by honey bees from various plant sources and has been used as a traditional folk medicine since ca 300 BC. Nowadays, the use of evidence-based complementary and alternative medicine (CAM) is increasing rapidly and so is the use of propolis in order to treat or support the treatment of various diseases. Much attention has been focused on propolis from <I>Populus</I> sp. (Salicaceae) and <I>Baccharis dracunculifolia</I> (Asteracea), but scientific information about the numerous other types of propolis is still sparse. We gathered six samples of red propolis in five states of Northeastern Brazil. The beehives were located near woody perennial shrubs along the sea and river shores. The bees were observed to collect red resinous exudates on <I>Dalbergia ecastophyllum (L) Taub</I>. (Leguminosae) to make propolis. The flavonoids of propolis and red resinous exudates were investigated using reversed-phase high-performance liquid chromatography and reversed-phase high-performance thin-layer chromatography. We conclude that the botanical origin of the reddish propolis is <I>D. ecastophyllum</I>. In areas where this source (<I>D. ecastophyllum</I>) was scarce or missing, bees were collecting resinous material from other plants. Propolis, which contained the chemical constituents from the main botanical origin, showed higher antimicrobial activity.</p>
]]></description>
<dc:creator><![CDATA[Daugsch, A., Moraes, C. S., Fort, P., Park, Y. K.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem057</dc:identifier>
<dc:title><![CDATA[Brazilian Red Propolis--Chemical Composition and Botanical Origin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>441</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>435</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/443?rss=1">
<title><![CDATA[Skin Impedance Measurements for Acupuncture Research: Development of a Continuous Recording System]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/443?rss=1</link>
<description><![CDATA[
<p>Skin impedance at acupuncture points (APs) has been used as a diagnostic/therapeutic aid for more than 50 years. Currently, researchers are evaluating the electrophysiologic properties of APs as a possible means of understanding acupuncture's mechanism. To comprehensively assess the diagnostic, therapeutic and mechanistic implications of acupuncture point skin impedance, a device capable of reliably recording impedances from 100 k to 50 M at multiple APs over extended time periods is needed. This article describes design considerations, development and testing of a single channel skin impedance system (hardware, control software and customized electrodes). The system was tested for accuracy against known resistors and capacitors. Two electrodes (the AMI and the ORI) were compared for reliability of recording over 30 min. Two APs (LU 9 and PC 6) and a nearby non-AP site were measured simultaneously in four individuals for 60 min. Our measurement system performed accurately (within 5%) against known resistors (580 k&ndash;10 M) and capacitors (10 nF&ndash;150 nF). Both the AMI electrode and the modified ORI electrode recorded skin impedance reliably on the volar surface of the forearm (<I>r</I> = 0.87 and <I>r</I> = 0.79, respectively). In four of four volunteers tested, skin impedance at LU 9 was less than at the nearby non-AP site. In three of four volunteers skin impedance was less at PC 6 than at the nearby non-AP site. We conclude that our system is a suitable device upon which we can develop a fully automated multi-channel device capable of recording skin impedance at multiple APs simultaneously over 24 h.</p>
]]></description>
<dc:creator><![CDATA[Colbert, A. P., Yun, J., Larsen, A., Edinger, T., Gregory, W. L., Thong, T.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem060</dc:identifier>
<dc:title><![CDATA[Skin Impedance Measurements for Acupuncture Research: Development of a Continuous Recording System]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>450</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>443</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/451?rss=1">
<title><![CDATA[Patient Disclosure about Herb and Supplement Use among Adults in the US]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/451?rss=1</link>
<description><![CDATA[
<p>Analyses of 2002 National Health Interview supplement on complementary and alternative medicine (NHI%AM) indicate that approximately 38 million adults in the US (18.9% of the population) used natural herbs or supplements in the preceding 12 months, but only one-third told their physician about this use. The objectives of this study are: (i) to determine subpopulation rates of patient&ndash;physician communication about herbal product and natural supplement use and (ii) to identify the relative influence of patient factors and interaction factors associated with patient-physician communication about herb and supplement use. Logistic secondary analysis was done by using the complementary and alternative medicine supplement of the 2002 National Health Interview Survey. Subjects were a random stratified sample of US adults who used herbs in the past 12 months (<I>n</I> = 5 196) and self-reported rates of disclosure to physicians about herb and supplement use. Results show that disclosure rates were significantly lower for males, younger adults, racial and ethnic minorities and less intensive users of medical care. Across subpopulations, disclosure was the exception rather than the norm. Given the potential risks of delayed or inappropriate treatment and adverse drug reactions and interactions, physicians should be aware of herb and supplement use and counsel patients on the potential risks and benefits of these treatments.</p>
]]></description>
<dc:creator><![CDATA[Kennedy, J., Wang, C.-C., Wu, C.-H.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem045</dc:identifier>
<dc:title><![CDATA[Patient Disclosure about Herb and Supplement Use among Adults in the US]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>456</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>451</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/457?rss=1">
<title><![CDATA[Tai Chi for Disease Activity and Flexibility in Patients with Ankylosing Spondylitis--A Controlled Clinical Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/457?rss=1</link>
<description><![CDATA[
<p>We investigated the effects of <I>tai chi</I> on disease activity, flexibility and depression in patients with ankylosing spondylitis (AS). We allocated 40 patients to either a <I>tai chi</I> treatment group or a no-treatment control group. The <I>tai chi</I> group performed 60 min of <I>tai chi</I> twice weekly for eight consecutive weeks and 8 weeks of home-based <I>tai chi</I>, after which the group showed significant improvement in disease activity and flexibility compared to the control group. All outcome measures were significantly lower in the <I>tai chi</I> group than they were during pre-treatment, while they did not change in the control group. These findings suggest that <I>tai chi</I> can improve disease activity and flexibility for patients with AS. <I>Tai chi</I> is an easily accessible therapy for patients and, as such, may be an effective intervention for AS. However, we cannot completely discount the possibility that the placebo effect was responsible for the improvement.</p>
]]></description>
<dc:creator><![CDATA[Lee, E.-N., Kim, Y.-H., Chung, W. T., Lee, M. S.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem048</dc:identifier>
<dc:title><![CDATA[Tai Chi for Disease Activity and Flexibility in Patients with Ankylosing Spondylitis--A Controlled Clinical Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>462</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>457</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/463?rss=1">
<title><![CDATA[A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/463?rss=1</link>
<description><![CDATA[
<p><I>&lsquo;Oketsu&rsquo;</I> is a pathophysiologic concept in Japanese traditional (<I>Kampo</I>) medicine, primarily denoting blood stasis/stagnant syndrome. Here we have explored plasma protein biomarkers and/or diagnostic algorithms for <I>&lsquo;Oketsu&rsquo;</I>. Sixteen rheumatoid arthritis (RA) patients were treated with <I>keishibukuryogan</I> (KBG), a representative <I>Kampo</I> medicine for improving <I>&lsquo;Oketsu&rsquo;</I>. Plasma samples were diagnosed as either having an <I>&lsquo;Oketsu&rsquo;</I> (<I>n</I> = 19) or &lsquo;non-<I>Oketsu</I>&rsquo; (<I>n</I> = 29) state according to Terasawa's <I>&lsquo;Oketsu&rsquo;</I> scoring system. Protein profiles were obtained by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) and hierarchical clustering and decision tree analyses were performed. KBG treatment for 4 or 12 weeks decreased the <I>&lsquo;Oketsu&rsquo;</I> scores significantly. SELDI protein profiles gave 266 protein peaks, whose expression was significantly different between the <I>&lsquo;Oketsu&rsquo;</I> and &lsquo;non-<I>Oketsu</I>&rsquo; states. Hierarchical clustering gave three major clusters (I, II, III). The majority (68.4%) of <I>&lsquo;Oketsu&rsquo;</I> samples were clustered into one cluster as the principal component of cluster I. The remaining <I>&lsquo;Oketsu&rsquo;</I> profiles constituted a minor component of cluster II and were all derived from patients cured of the <I>&lsquo;Oketsu&rsquo;</I> state at 12 weeks. Construction of the decision tree addressed the possibility of developing a diagnostic algorithm for <I>&lsquo;Oketsu&rsquo;</I>. A reduction in measurement/pre-processing conditions (from 55 to 16) gave a similar outcome in the clustering and decision tree analyses. The present study suggests that the pathophysiologic concept of <I>Kampo</I> medicine <I>&lsquo;Oketsu&rsquo;</I> has a physical basis in terms of the profile of blood proteins. It may be possible to establish a set of objective criteria for diagnosing <I>&lsquo;Oketsu&rsquo;</I> using a combination of proteomic and bioinformatics-based classification methods.</p>
]]></description>
<dc:creator><![CDATA[Matsumoto, C., Kojima, T., Ogawa, K., Kamegai, S., Oyama, T., Shibagaki, Y., Kawasaki, T., Fujinaga, H., Takahashi, K., Hikiami, H., Goto, H., Kiga, C., Koizumi, K., Sakurai, H., Muramoto, H., Shimada, Y., Yamamoto, M., Terasawa, K., Takeda, S., Saiki, I.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem049</dc:identifier>
<dc:title><![CDATA[A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>474</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>463</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/475?rss=1">
<title><![CDATA[Apitherapy: Usage And Experience In German Beekeepers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/475?rss=1</link>
<description><![CDATA[
<p>This study aimed to investigate the practice of apitherapy - using bee products such as honey, pollen, propolis, royal jelly and bee venom to prevent or treat illness and promote healing - among German beekeepers and to evaluate their experiences with these therapies. A questionnaire incorporating two instruments on beekeepers&rsquo; physical and mental health and working practice was included in three German beekeeping journals and readers were asked to complete it. The instrument included questions on the use of apitherapy. Simple descriptive methods, bivariate correlation, cross-tabulation and one-way ANOVA were used to analyze the data. Altogether 1059 completed questionnaires were received. The beekeepers reported the most effective and favorable therapeutic effects with honey, followed by propolis, pollen and royal jelly. The factors associated with successful experiences were: age, number of hives tended, health consciousness, positive experiences with one product and self-administration of treatment. Beekeepers were asked for which condition they would employ propolis and pollen. They reported that they used propolis most frequently to treat colds, wounds and burns, sore throats, gum disorders and also as a general prophylactic, while pollen was most commonly used as a general prophylactic and, less frequently, in treating prostate diseases. No adverse experiences were reported. The potential benefit of bee products is supported by the positive experiences of a large group of beekeepers who use some of these products to treat a wide range of conditions. The indications and treatments given here may be important in selecting bee products and designing future trials.</p>
]]></description>
<dc:creator><![CDATA[Hellner, M., Winter, D., von Georgi, R., Munstedt, K.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem052</dc:identifier>
<dc:title><![CDATA[Apitherapy: Usage And Experience In German Beekeepers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>479</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>475</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/481?rss=1">
<title><![CDATA[Do Japanese Style Acupuncture and Moxibustion Reduce Symptoms of the Common Cold?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/481?rss=1</link>
<description><![CDATA[
<p>We summarize the results from a series of investigations of Japanese style acupuncture and moxibustion therapies on symptoms of the common cold that have been conducted (FTLE 1999&ndash;03, supported by the Foundation for Training and Licensure Examination in Anma- Massage- Acupressure, Acupuncture and Moxibustion). We also discuss the various interventions and concerns that we faced during these investigations. The subjects were students and teachers. The pilot study (FTLE1999) of a two arm (real and non-treatment control) RCT at a Japanese acupuncture school showed that manual acupuncture to a specific needling point at the throat clearly reduced symptoms of the common cold. The first multi-center (five centers) RCT (FTLE 2000) revealed a significant reduction in cold symptoms, by general linear model analysis (between groups, <I>P</I> = 0.024). To reduce the technical variation, we employed indirect moxibustion to the neck points as a uniform intervention in the next project (FTLE 2001) without statistically significant results. Then we elongated the periods of treatment from 2 to a maximum of 12 weeks (FTLE 2002) with different interventions accompanied by 4 weeks follow-up. The results were still not statistically significant. As the final project, we tried to develop a new experimental design for individualized intervention by conducting <I>n</I>-of-1 trials using elderly subjects in a health care center but without detecting a clear effect. In conclusion, the safety of Japanese acupuncture or moxibustion was sufficiently demonstrated; however, a series of clinical trials could not offer convincing evidence to recommend the use of Japanese style acupuncture or moxibustion for preventing the common cold. Further studies are required as the present trials had several limitations.</p>
]]></description>
<dc:creator><![CDATA[Kawakita, K., Shichidou, T., Inoue, E., Nabeta, T., Kitakoji, H., Aizawa, S., Nishida, A., Yamaguchi, N., Takahashi, N., Sumiya, E., Okada, K., Umeda, T., Yano, T., Tanzawa, S.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem055</dc:identifier>
<dc:title><![CDATA[Do Japanese Style Acupuncture and Moxibustion Reduce Symptoms of the Common Cold?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>489</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>481</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/491?rss=1">
<title><![CDATA[Non Conventional Medicine in Italy. History, Problems, Prospects for Integration]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/491?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Nuzzi, R.]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem174</dc:identifier>
<dc:title><![CDATA[Non Conventional Medicine in Italy. History, Problems, Prospects for Integration]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>492</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>491</prism:startingPage>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/5/4/493?rss=1">
<title><![CDATA[Evidence Based Complementary and Alternative Medicine: List of Reviewers]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/5/4/493?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-11-21</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen076</dc:identifier>
<dc:title><![CDATA[Evidence Based Complementary and Alternative Medicine: List of Reviewers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>5</prism:volume>
<prism:endingPage>497</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>493</prism:startingPage>
<prism:section>List of Reviewers</prism:section>
</item>

</rdf:RDF>